Trial intelligence / Profile preview

Comparison of two lipid emulsions in total parenteral nutrition for critically ill ICU patients

2005-003542-33Phase 4Terminated

Sponsor
B. Braun
Start
May 2006
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in critical illness comparing Lipofundin MCT/LCT arm with Lipoplus arm (2 arms). Primary endpoints: Incidence of nosocomial infection, Ventilator-associated pneumonia incidence and 1 more. Started May 2006; status: terminated.

02

Drugs

medium-chain triglycerides + long-chain triglyceridesLipidem
03

Conditions

critical illness

Beyond the preview

Go deeper on 2005-003542-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003542-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call